Synergistic antimicrobial compositions comprising 3-benzobthiene-2-yl-5,6-dihydro-1,4,2-oxathiazine-4-oxide
CA 2768012 A1 · Owner: Janssen Pharmaceutica N.V. · Inventors: Tanaka, Ikuya; Ohnishi, Toshimasa
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention concerns antimicrobial compositions that are useful for industrial applications. More specifically it concerns antimicrobial , compositions that by combining 3-benzobthiene-2-yl-5,6-dihydro-1,4,2-oxathiazine-4-oxide , and one or more of 1-(3-iodo-2-propynyl)oxymethoxy-4--methoxy benzene 1-chloro-4-(3-iodo-2-propynyl)oxymethoxy benzene Zinc 2--pyridine , thiol-1-oxide, Copper 2-pyridine thiol-1-oxide 2-pyridine thiol-1--oxide , sodium salt 2,2-dithio-bis(pyridine-1-oxide), 2-methylthio-4-t-butyl amino-6-cyclopropyl amino-s-triazine, 3-iodo-2-propynyl butylcarbamate (IPBC) 2-(n-octyl)-3(2H)-isothiazolone (OIT), 4,5-dichloro-2-(n-octyl)-3(2H)-isothiazolone , (DCOIT), …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 4, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 4, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 4, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.